PATENT CLAIM ANALYSIS

Application Number: 15887830
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "045000"]

Abstract:
The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.

Claim (Index 32):
The method according to  claim 30 , wherein the pharmaceutical composition is administered to the subject for 14 days or more.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.26829
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15750811', '15750809', '14686535', '15117711', '15621857']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.773694230219676
- 35 USC 102 Novelty (BERT): 0.5305150138059957
- Combined Prediction Score: 0.749376308578308
- Mean Citation Score: 321.703724
- Max Citation Score: 336.75778
- Similarity Product: 192.6747969342637

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test